Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

Thousands of families are waiting to access services – we would like to reflect your stories in a forthcoming article.

ChildServe works to help young children with special health care needs, as part of that mission they’re helping students with ...

Regeneron's DB-OTO gene therapy shows improved hearing in 10 of 11 children in the CHORD trial, with three reaching ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...

Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude ...

As presented at ARO, 10 of 11 children with at least one post-treatment assessment showed notable improvements in hearingSpeech and development ...

Painful monthly penicillin injections could be a thing of the past with Griffith University researchers, in collaboration ...